Literature DB >> 12951209

Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays.

Patti E Gravitt1, Cheri Peyton, Cosette Wheeler, Raymond Apple, Russell Higuchi, Keerti V Shah.   

Abstract

A reproducibility study was designed to assess within-assay, between-day, and interlaboratory variability of three real-time PCR assays targeting HPV 16, HPV 18, and the human glyceraldehyde-3-phosphate dehydrogenase (GAPDH) pseudogenes. Fifteen HPV 16 and fifteen HPV 18 cervical swab samples were amplified in triplicate by GAPDH and HPV 16 and by GAPDH and HPV 18 assays, respectively. All samples were amplified undiluted and at a 1:10 dilution on 2 separate days in the same laboratory, and the same samples were amplified in a separate laboratory. HPV 16 and HPV 18 normalized viral load is reported as the number of HPV genomes per 20000 GAPDH copies. The analytic specificity of the HPV 16 and 18 assays was 100 and 97%, respectively. The intraclass correlation coefficients (ICC) were 0.99, 0.97, and 0.98 for HPV 16, HPV 18, and GAPDH, respectively, indicating that the variability due to experimental error was very low. Ten-fold differences in viral load could be readily discriminated across a six order of magnitude dynamic range (ca. 5-5x10(6) copies). Power of discrimination was increased at higher target concentrations (>5000 copies). The correlation of normalized HPV 16 and 18 viral load was high between the two laboratories (Spearman rho (rho)=0.96 and 0.87, respectively). These HPV 16 and HPV 18 quantitative PCR assays with GAPDH normalization are reproducibly quantitative over a broad linear dynamic range allowing for application in epidemiologic studies for measurement of viral load.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951209     DOI: 10.1016/s0166-0934(03)00186-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  35 in total

1.  Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Authors:  Carole Fakhry; Barbara T Rosenthal; Douglas P Clark; Maura L Gillison
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

2.  Enhanced detection and typing of human papillomavirus (HPV) DNA in anogenital samples with PGMY primers and the Linear array HPV genotyping test.

Authors:  François Coutlée; Danielle Rouleau; Patrick Petignat; Georges Ghattas; Janet R Kornegay; Peter Schlag; Sean Boyle; Catherine Hankins; Sylvie Vézina; Pierre Coté; John Macleod; Hélène Voyer; Pierre Forest; Sharon Walmsley; Eduardo Franco
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

3.  Human papillomavirus 16-associated cervical intraepithelial neoplasia in humans excludes CD8 T cells from dysplastic epithelium.

Authors:  Cornelia L Trimble; Rachael A Clark; Christopher Thoburn; Nicole C Hanson; Jodie Tassello; Denise Frosina; Ferdynand Kos; Jessica Teague; Ying Jiang; Nicole C Barat; Achim A Jungbluth
Journal:  J Immunol       Date:  2010-10-29       Impact factor: 5.422

4.  Establishment and characterization of a squamous cell carcinoma cell line, designated hZK-1, derived from a metastatic lymph node tumor of the tongue.

Authors:  Tetsuya Hirabayashi; Haruka Takahashi; Miho Watanabe; Toshiaki Tachibana
Journal:  Hum Cell       Date:  2017-03-04       Impact factor: 4.174

5.  Virus detection and semiquantitation in explanted heart tissues of idiopathic dilated cardiomyopathy adult patients by use of PCR coupled with mass spectrometry analysis.

Authors:  Yohan Nguyen; Fanny Renois; Nicolas Leveque; Delphine Giusti; Marcus Picard-Maureau; Patrick Bruneval; Paul Fornes; Laurent Andreoletti
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

6.  Naturally occurring systemic immune responses to HPV antigens do not predict regression of CIN2/3.

Authors:  Cornelia L Trimble; Shiwen Peng; Christopher Thoburn; Ferdynand Kos; T C Wu
Journal:  Cancer Immunol Immunother       Date:  2009-12-13       Impact factor: 6.968

7.  Oral human papillomavirus infection before and after treatment for human papillomavirus 16-positive and human papillomavirus 16-negative head and neck squamous cell carcinoma.

Authors:  Yuri Agrawal; Wayne M Koch; Weihong Xiao; William H Westra; Anna L Trivett; David E Symer; Maura L Gillison
Journal:  Clin Cancer Res       Date:  2008-11-01       Impact factor: 12.531

8.  A pilot study of pNGVL4a-CRT/E7(detox) for the treatment of patients with HPV16+ cervical intraepithelial neoplasia 2/3 (CIN2/3).

Authors:  Ronald D Alvarez; Warner K Huh; Sejong Bae; Lawrence S Lamb; Michael G Conner; Jean Boyer; Chenguang Wang; Chien-Fu Hung; Elizabeth Sauter; Mihaela Paradis; Emily A Adams; Shirley Hester; Bradford E Jackson; T C Wu; Cornelia L Trimble
Journal:  Gynecol Oncol       Date:  2015-11-23       Impact factor: 5.482

9.  Detection of anatid herpesvirus 1 gC gene by TaqMan fluorescent quantitative real-time PCR with specific primers and probe.

Authors:  Qing Zou; Kunfeng Sun; Anchun Cheng; Mingshu Wang; Chao Xu; Dekang Zhu; Renyong Jia; Qihui Luo; Yi Zhou; Zhengli Chen; Xiaoyue Chen
Journal:  Virol J       Date:  2010-02-13       Impact factor: 4.099

10.  Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR.

Authors:  William T Seaman; Elizabeth Andrews; Marion Couch; Erna M Kojic; Susan Cu-Uvin; Joel Palefsky; Allison M Deal; Jennifer Webster-Cyriaque
Journal:  Virol J       Date:  2010-08-19       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.